Clinical Trials Directory

Trials / Sponsors / Desitin Arzneimittel GmbH

Desitin Arzneimittel GmbH

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedBioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects
Pharmacokinetic Analysis, Bioequivalence, Health Adult Subjects
Phase 12025-12-17
CompletedBioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Relea
Multiple Drug Use
Phase 12023-09-22
CompletedBioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.
Food-drug Interaction
Phase 12023-09-11
CompletedSingle-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditio
Fasting
Phase 12023-04-03
CompletedEfficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
Obstructive Sleep Apnea
Phase 22021-11-23
CompletedPharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administratio
Fasted State
Phase 12014-03-01
CompletedESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epile
Epilepsy
—2010-02-01
CompletedInfluence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Com
Idiopathic Parkinson's Disease
Phase 32010-01-01
CompletedPIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy
Parkinson's Disease
—2009-06-01
CompletedSEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-
Parkinson's Disease
—2008-03-01
CompletedSEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease
Parkinson's Disease
—2008-01-01
TerminatedEXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epile
Partial Epilepsy
Phase 32006-10-01
CompletedValproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening
Epilepsy
—2005-01-01